Utah Medical Products, Inc. | ||||||||||||||||||||||||
Exhibit 12 to Registration Statement on Form S-3 | ||||||||||||||||||||||||
Calculation of ratio of earnings to fixed charges pursuant to Item 503(d) of Regulation S-K | ||||||||||||||||||||||||
Nine months | ||||||||||||||||||||||||
ended | Year ended December 31, | |||||||||||||||||||||||
30-Sep-12 | 2011 | 2010 | 2009 | 2008 | 2007 | |||||||||||||||||||
Fixed charges | ||||||||||||||||||||||||
(a) interest expensed and capitalized | $ | 516,469 | $ | 859,366 | $ | 25,077 | $ | 51,088 | $ | 198,154 | $ | 270,315 | ||||||||||||
(b) amortized premiums, discounts and capitalized expenses related to indebtedness | - | - | - | - | - | - | ||||||||||||||||||
(c) estimated interest within rental expense | 92,731 | 73,390 | 30,956 | 56,204 | 57,122 | 56,048 | ||||||||||||||||||
(d) preference security dividend requirements of subsidiaries | - | - | - | - | - | - | ||||||||||||||||||
Total fixed charges | $ | 609,200 | $ | 932,756 | $ | 56,033 | $ | 107,292 | $ | 255,276 | $ | 326,363 | ||||||||||||
Earnings | ||||||||||||||||||||||||
Total of: | ||||||||||||||||||||||||
(a) Pretax income from continuing operations: | $ | 11,215,358 | $ | 11,079,889 | $ | 9,040,579 | $ | 9,579,656 | $ | 10,776,683 | $ | 12,038,193 | ||||||||||||
(b) fixed charges | 609,200 | 932,756 | 56,033 | 107,292 | 255,276 | 326,363 | ||||||||||||||||||
(c) amortization of capitalized interest | - | - | - | - | - | - | ||||||||||||||||||
(d) distrubuted income of equity investees | - | - | - | - | - | - | ||||||||||||||||||
(e) issuer's share of of pre-tax losses of equity investees | - | - | - | - | - | - | ||||||||||||||||||
11,824,558 | 12,012,645 | 9,096,612 | 9,686,948 | 11,031,959 | 12,364,556 | |||||||||||||||||||
Less: | ||||||||||||||||||||||||
(a) interest capitalized | - | - | - | - | - | - | ||||||||||||||||||
(b) preference security dividend requirements of consolidated subsidiaries | - | - | - | - | - | - | ||||||||||||||||||
(c) minority interest in pre-tax income of subsidiaries that have not incurred fixed charges | - | - | - | - | - | - | ||||||||||||||||||
- | - | - | - | - | - | |||||||||||||||||||
Total Earnings | $ | 11,824,558 | $ | 12,012,645 | $ | 9,096,612 | $ | 9,686,948 | $ | 11,031,959 | $ | 12,364,556 | ||||||||||||
Ratio of earnings to fixed charges | 19.4 | 12.9 | 162.3 | 90.3 | 43.2 | 37.9 |
- UTMD Dashboard
- Financials
- Filings
- ETFs
- Insider
- Institutional
- Shorts
- News
- Patents
-
S-3/A Filing
Utah Medical Products (UTMD) S-3/AShelf registration (amended)
Filed: 13 Nov 12, 12:00am